EUVIMEDEUVIMED entdecken
Crossref

Discovery of Novel Mcl-1 Inhibitors with a 3-Substituted-1 H -indole-1-yl Moiety Binding to the P1–P3 Pockets to Induce Apoptosis in Acute Myeloid Leukemia Cells

Hongguang Deng, Jingyi Zhang, Liang Liu, Hong Zhang, Yu Han, Linlin Wu, Yongkui Jing iD, Min Huang, Linxiang Zhao iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c00643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Hongguang Deng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China. Hauptthemen laut MEDLINE: Myeloid Cell Leukemia Sequence 1 Protein, Apoptosis, Leukemia, Myeloid, Acute, Indoles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Liaoning Revitalization Talents Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mcl-1 is a main antiapoptotic protein in acute myeloid leukemia (AML) and is used as a target to develop inhibitors. Currently, potent Mcl-1 inhibitors primarily interact with the P2-P4 pockets of Mcl-1, but pharmacological modulation by targeting the P1 pocket is less explored. We designed a series of 1H-indole-2-carboxylic acid compounds as novel Mcl-1 inhibitors occupying the P1-P3 pockets and evaluated their Mcl-1 inhibition and apoptosis induction in AML cells. Two-dimensional 15N-HSQC spectroscopy indicated that 47 (Ki = 24 nM) bound to the BH3 binding groove, occupied the P1 pocket in Mcl-1, and formed interactions with Lys234 and Val249. 47 exhibited good microsomal stability and pharmacokinetic profiles, with low potential risk of cardiotoxicity. 47 inhibited tumor growth in HL-60 and THP-1 xenograft models with growth inhibition rate of 63.7% and 57.4%, respectively. Collectively, 47 represents a novel Mcl-1 inhibitor targeting the P1-P3 pockets with excellent antileukemia effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid Cell Leukemia Sequence 1 ProteinApoptosisLeukemia, Myeloid, AcuteIndolesAntineoplastic AgentsHumansAnimalsStructure-Activity RelationshipMiceXenograft Model Antitumor AssaysDrug DiscoveryCell ProliferationCell Line, TumorHL-60 CellsBinding Sites

Substanzen

Myeloid Cell Leukemia Sequence 1 ProteinIndolesAntineoplastic AgentsMCL1 protein, human

Autor:innen und Institutionen

  • Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Liaoning Key Laboratory of Targeting Drugs for Hematological Malignancies, Shenyang Pharmaceutical University, Shenyang 110016, China.

ORCID-Profile: Yongkui Jing, Linxiang Zhao

Förderung

  • Liaoning Revitalization Talents Program
  • National Natural Science Foundation of China

Zitieren

APA

Deng, H., Zhang, J., Liu, L., Zhang, H., Han, Y., Wu, L., Jing, Y., Huang, M., & Zhao, L. (2024). Discovery of Novel Mcl-1 Inhibitors with a 3-Substituted-1 H -indole-1-yl Moiety Binding to the P1–P3 Pockets to Induce Apoptosis in Acute Myeloid Leukemia Cells. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00643

Vancouver

Deng H, Zhang J, Liu L, Zhang H, Han Y, Wu L, et al. Discovery of Novel Mcl-1 Inhibitors with a 3-Substituted-1 H -indole-1-yl Moiety Binding to the P1–P3 Pockets to Induce Apoptosis in Acute Myeloid Leukemia Cells. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00643

BibTeX
@article{Deng2024,
  author = {Deng, Hongguang and Zhang, Jingyi and Liu, Liang and Zhang, Hong and Han, Yu and Wu, Linlin and Jing, Yongkui and Huang, Min and Zhao, Linxiang},
  title = {Discovery of Novel Mcl-1 Inhibitors with a 3-Substituted-1 H -indole-1-yl Moiety Binding to the P1–P3 Pockets to Induce Apoptosis in Acute Myeloid Leukemia Cells},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c00643}
}
Kostenlos starten →